NXTC: NextCure, Inc. Stock

by  •  • Comments Off on NXTC: NextCure, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 21.79
Enterprise Value ($M) -5.91
Book Value ($M) 75.59
Book Value / Share 2.70
Price / Book 0.29
NCAV ($M) 63.94
NCAV / Share 2.28
Price / NCAV 0.34

Profitability (mra)
Return on Invested Capital (ROIC) -0.72
Return on Assets (ROA) -0.46
Return on Equity (ROE) -0.51

Liquidity (mrq)
Quick Ratio 9.07
Current Ratio 9.07

Balance Sheet (mrq) ($M)
Current Assets 78.69
Assets 90.34
Liabilities 14.75
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Logos Global Management LP 8.90 24.97
11-13 13G/A Affinity Asset Advisors, LLC 8.22 37.65
03-08 13D/A Orbimed Advisors Llc 4.50 -53.23
01-19 13G/A Millennium Management Llc 4.10 -21.35

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-14 5,532 28,072 19.71
2025-01-13 7,429 80,337 9.25
2025-01-10 11,126 126,147 8.82

(click for more detail)

Similar Companies
NMRA – Neumora Therapeutics, Inc. NUVL – Nuvalent, Inc.
NVAX – Novavax, Inc. OGI – Organigram Holdings Inc.
OLMA – Olema Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io